Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion type Assertion NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_head.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion description "[Our results indicate that p16INK4a promoter hypermethylation predicts a poor 5-year survival rates for patients with resectable non-small cell lung cancer, particularly for those with early stage tumors, whereas RASSF1A promoter hypermethylation is a profound prognostic predictor for patients with locally advanced non-small cell lung cancer, suggesting an important role of RASSF1A in non-small cell lung cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_provenance.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion evidence source_evidence_literature NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_provenance.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion SIO_000772 15447998 NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_provenance.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion wasDerivedFrom befree-20140225 NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_provenance.
- NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_assertion wasGeneratedBy ECO_0000203 NP187192.RAX_Rusvnn4ircwIpI-rb1zEGgPfdMzvxdIQ2UoH1rNFM130_provenance.